Are you a healthcare professional seeking clarity on the evolving treatments for sickle cell disease (SCD)?
In this 20-minute episode, experts from cellular therapy and bone marrow transplantation (BMT) explore key updates in SCD care, including curative therapies, gene-editing innovations, and BMT approaches. They address practical challenges in integrating these treatments into practice and discuss strategies to improve access and outcomes. Tune in to discover how collaboration between cellular therapy and BMT providers is transforming care and paving the way for better patient experiences.
Learning Objectives
Understand recent advancements in curative therapies, including gene editing and BMT, for sickle cell disease.
Identify key challenges and barriers to integrating new treatments into clinical practice for SCD patients.
Explore collaborative care strategies between cellular therapy and BMT providers to improve patient outcomes and access.
Podden och tillhörande omslagsbild på den här sidan tillhör American Society of Hematology. Innehållet i podden är skapat av American Society of Hematology och inte av, eller tillsammans med, Poddtoppen.
